EZH2 and small cell lung carcinoma: EZH2, which is the catalytic subunit of the “polycomb repressive complex 2” (PRC2), is upregulated in SCLC cells upon the inactivation of the RB-E2F pathway, leading to a silencing of tumour suppressor genes and ultimately promoting SCLC cell proliferation [25,30,33].